Product Information
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.3110 per EA under NDC 69097053302. Its NADAC has been published 443 times since Feb 28, 2018.
FDA first approved this application on Jan 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Cipla USA Inc.NDC
69097053302
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA078800FDA Approved
1/26/2018
TE Code
AB
On Market Since
1/26/2018
Pharmacological Classes
Price Statistics
The NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has been published 443 times since Feb 28, 2018, and over the history we have for it it has declined 98.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3110 per EA |
|---|---|
| All-time high | $27.7425 (Mar 14, 2018) |
| All-time low | $0.3107 (Jun 17, 2026) |
| 52-week high | $0.3960 |
| 52-week low | $0.3107 |
| Median price | $0.5673 |
| Average price | $1.1742 |
| Largest weekly change | -87.4% (Apr 18, 2018) |
| Weeks tracked | 443 |
| Tracking since | Feb 28, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, manufactured by Cipla USA Inc., is $0.3110 per EA (NDC 69097053302), effective Aug 19, 2026.
How has the price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has declined 98.9%. It has been tracked across 443 weekly CMS publications since Feb 28, 2018.
What are the highest and lowest recorded NADAC prices for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
Since Feb 28, 2018, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has ranged from a low of $0.3107 (Jun 17, 2026) to a high of $27.7425 (Mar 14, 2018), with a median of $0.5673 per EA.
Are there cheaper alternatives to TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (NDC 69097053302) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.